Autolus Therapeutics (AUTL) Revenue (2017 - 2025)
Autolus Therapeutics (AUTL) posted quarterly Revenue of $24.3 million for Q4 2025, up 83655.17% year-on-year from N/an in Q4 2024, and up 14.6% on a QoQ basis from $21.2 million in Q3 2025.
Autolus Therapeutics (AUTL) Revenue (2017 - 2025) Analysis & Trends
Autolus Therapeutics (AUTL) has reported Revenue for 9 consecutive years, with $24.3 million the latest figure, recorded in Q4 2025.
- Quarterly Revenue rose 83655.17% year-over-year to $24.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $75.4 million (up 644.28% YoY) and the FY2025 annual result came in at $75.4 million, up 644.94% from the prior year.
- Revenue grew to $24.3 million in Q4 2025 per AUTL's latest filing, from $21.2 million in the prior quarter.
- Over the last five years, Revenue for AUTL reached as high as $24.3 million in Q4 2025 and fell as low as $29000.0 in Q4 2024.
- A 5-year average of $6.8 million and a median of $1.9 million in 2021 frame the typical range for Revenue.
- Annual changes were most pronounced in 2023 — Revenue slumped 82.86% — and 2025, when it jumped 83655.17%.
- Year by year, Revenue stood at $236000.0 in 2021, then surged by 1450.42% to $3.7 million in 2022, then slumped by 88.9% to $406000.0 in 2023, then slumped by 92.86% to $29000.0 in 2024, then soared by 83655.17% to $24.3 million in 2025.
- According to Business Quant data, Revenue over the past three periods registered $24.3 million, $21.2 million, and $20.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.51 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.56 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Autolus Therapeutics | 404.53 Mn | 103.82 Mn | -1.04 Mn | 24.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 24.29 Mn |
| Sep 30, 2025 | 21.19 Mn |
| Jun 30, 2025 | 20.92 Mn |
| Mar 31, 2025 | 8.98 Mn |
| Dec 31, 2024 | 29,000.00 |
| Mar 31, 2024 | 10.10 Mn |
| Sep 30, 2023 | 406,000.00 |
| Mar 31, 2023 | 1.29 Mn |
| Dec 31, 2022 | 3.66 Mn |
| Sep 30, 2022 | 2.37 Mn |
| Mar 31, 2022 | 166,000.00 |
| Sep 30, 2021 | 236,000.00 |
| Jun 30, 2021 | 1.51 Mn |
| Mar 31, 2021 | 269,000.00 |
| Dec 31, 2020 | 404,000.00 |
| Sep 30, 2020 | 438,000.00 |
| Jun 30, 2020 | 293,000.00 |
| Mar 31, 2020 | 338,000.00 |
| Jun 30, 2019 | 2.30 Mn |
| Mar 31, 2019 | 1.96 Mn |